Ontology highlight
ABSTRACT:
SUBMITTER: Hersey P
PROVIDER: S-EPMC6094707 | biostudies-literature | 2014 Nov
REPOSITORIES: biostudies-literature
Hersey Peter P Kakavand Hojabr H Wilmott James J van der Westhuizen Andre A Gallagher Stuart S Gowrishankar Kavitha K Scolyer Richard R
Melanoma management 20141101 2
The introduction of immunotherapy based on the blockade of the PD1/PD-L1 checkpoints has been associated with high response rates and durable remissions of disease in patients with metastatic melanoma, to the extent that it is now considered the standard of care for a wide range of patients, irrespective of their <i>BRAF</i> or <i>NRAS</i> mutation status. In addition, more frequent follow-up of patients who are at high risk of recurrence after surgical treatment appears to be justified, as does ...[more]